Capsugel® Vcaps® Plus DPI capsules are the only Capsugel® Zephyr™ portfolio HPMC offering with no gelling agents available on the market. They are a high-quality capsule solution with a glossy surface and optimal transparency. Capsugel® Vcaps® Plus DPI capsules are robust capsules with a LOD (loss on drying) below 9% or up to less than 2.2% LWA (low water activity). The standard offering is available with narrow weight distribution and a range of customizable color and print options.
Every product development need varies based on the desired performance of the finished product. Lonza partners with its customers to closely match specific requirements and leverages a wide range of customization services for its Capsugel® Zephyr™ capsule portfolio.
Learn more about our capabilities and which Capsugel® Zephyr ™ product is right for your next project.
Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication.
Within the dry powder inhalation application fields, Lonza offers a portfolio of high-quality capsule solutions based on different polymers, tailored to enable consistent and optimal release performance. Building on a history of innovation in polymer science and capsule engineering, the Capsugel® brand, now part of Lonza, offers a suite of HPMC and alternate polymer capsules for the pharmaceutical world.